• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对 SARS-CoV-2 的生发中心 B 细胞反应。

The germinal centre B cell response to SARS-CoV-2.

机构信息

Division of Allergy and Immunology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.

出版信息

Nat Rev Immunol. 2022 Jan;22(1):7-18. doi: 10.1038/s41577-021-00657-1. Epub 2021 Dec 6.

DOI:10.1038/s41577-021-00657-1
PMID:34873279
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8647067/
Abstract

The germinal centre (GC) response is critical for the generation of affinity-matured plasma cells and memory B cells capable of mediating long-term protective immunity. Understanding whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or vaccination elicits a GC response has profound implications for the capacity of responding B cells to contribute to protection against infection. However, direct assessment of the GC response in humans remains a major challenge. Here we summarize emerging evidence for the importance of the GC response in the establishment of durable and broad immunity against SARS-CoV-2 and discuss new approaches to modulate the GC response to better protect against newly emerging SARS-CoV-2 variants. We also discuss new findings showing that the GC B cell response persists in the draining lymph nodes for at least 6 months in some individuals following vaccination with SARS-CoV-2 mRNA-based vaccines.

摘要

生发中心(GC)反应对于产生亲和力成熟的浆细胞和记忆 B 细胞至关重要,这些细胞能够介导长期的保护性免疫。了解严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染或疫苗接种是否引发 GC 反应,对 B 细胞应对感染的能力产生深远影响。然而,直接评估人类的 GC 反应仍然是一个主要挑战。在这里,我们总结了 GC 反应在建立对 SARS-CoV-2 的持久和广泛免疫中的重要性的新证据,并讨论了调节 GC 反应以更好地预防新出现的 SARS-CoV-2 变体的新方法。我们还讨论了新的发现,表明在接种 SARS-CoV-2 mRNA 疫苗后,一些人的引流淋巴结中的 GC B 细胞反应至少持续 6 个月。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/8647067/1b09d8ffadc9/41577_2021_657_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/8647067/ae6c145b6b7f/41577_2021_657_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/8647067/9b1e31e86638/41577_2021_657_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/8647067/26d47964fc8e/41577_2021_657_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/8647067/f68a3c2aa01c/41577_2021_657_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/8647067/1b09d8ffadc9/41577_2021_657_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/8647067/ae6c145b6b7f/41577_2021_657_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/8647067/9b1e31e86638/41577_2021_657_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/8647067/26d47964fc8e/41577_2021_657_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/8647067/f68a3c2aa01c/41577_2021_657_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/8647067/1b09d8ffadc9/41577_2021_657_Fig5_HTML.jpg

相似文献

1
The germinal centre B cell response to SARS-CoV-2.针对 SARS-CoV-2 的生发中心 B 细胞反应。
Nat Rev Immunol. 2022 Jan;22(1):7-18. doi: 10.1038/s41577-021-00657-1. Epub 2021 Dec 6.
2
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.SARS-CoV-2 mRNA 疫苗可诱导持久的人体生发中心反应。
Nature. 2021 Aug;596(7870):109-113. doi: 10.1038/s41586-021-03738-2. Epub 2021 Jun 28.
3
What the Omicron wave is revealing about human immunity.奥密克戎毒株浪潮揭示了人类免疫力的哪些情况。
Nature. 2022 Feb;602(7895):22-25. doi: 10.1038/d41586-022-00214-3.
4
Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain.mRNA 疫苗对小鼠进行同侧或对侧增强免疫可提供针对 SARS-CoV-2 奥密克戎株的等效免疫和保护。
J Virol. 2024 Sep 17;98(9):e0057424. doi: 10.1128/jvi.00574-24. Epub 2024 Aug 28.
5
SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation.SARS-CoV-2 mRNA 疫苗可促进与中和抗体产生相关的强效抗原特异性生发中心反应。
Immunity. 2020 Dec 15;53(6):1281-1295.e5. doi: 10.1016/j.immuni.2020.11.009. Epub 2020 Nov 21.
6
Unravelling humoral immunity in SARS-CoV-2: Insights from infection and vaccination.解析 SARS-CoV-2 的体液免疫:感染和疫苗接种的启示。
Hum Antibodies. 2024;32(3):85-106. doi: 10.3233/HAB-230017.
7
Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination.抗体反馈调节 SARS-CoV-2 mRNA 疫苗接种后的免疫记忆。
Nature. 2023 Jan;613(7945):735-742. doi: 10.1038/s41586-022-05609-w. Epub 2022 Dec 6.
8
Germinal centre-driven maturation of B cell response to mRNA vaccination.mRNA 疫苗接种中 B 细胞反应的生发中心驱动成熟。
Nature. 2022 Apr;604(7904):141-145. doi: 10.1038/s41586-022-04527-1. Epub 2022 Feb 15.
9
Affinity-independent memory B cell origin of the early antibody-secreting cell response in naive individuals upon SARS-CoV-2 vaccination.SARS-CoV-2 疫苗接种后,未感染个体早期抗体分泌细胞反应中亲和力非依赖的记忆 B 细胞起源。
Immunity. 2024 Sep 10;57(9):2191-2201.e5. doi: 10.1016/j.immuni.2024.07.023. Epub 2024 Aug 20.
10
Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine.优化非修饰 mRNA COVID-19 疫苗的非编码区。
Nature. 2022 Jan;601(7893):410-414. doi: 10.1038/s41586-021-04231-6. Epub 2021 Nov 18.

引用本文的文献

1
Mucosal immunity and vaccination strategies: current insights and future perspectives.黏膜免疫与疫苗接种策略:当前见解与未来展望。
Mol Biomed. 2025 Aug 20;6(1):57. doi: 10.1186/s43556-025-00301-7.
2
Spatial morphoproteomic features predict disease states from tissue architectures.空间形态蛋白质组学特征可从组织结构预测疾病状态。
iScience. 2025 Jul 24;28(8):113204. doi: 10.1016/j.isci.2025.113204. eCollection 2025 Aug 15.
3
Improved mRNA-based RSV vaccine with PreF forming enveloped virus-like particles.基于mRNA的改良呼吸道合胞病毒疫苗,前体融合蛋白(PreF)形成包膜病毒样颗粒。

本文引用的文献

1
Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant.新冠病毒德尔塔变异株引发的大型溯源清晰的暴发中的病毒感染和传播。
Nat Commun. 2022 Jan 24;13(1):460. doi: 10.1038/s41467-022-28089-y.
2
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans.SARS-CoV-2 mRNA 疫苗可在人体内引发强烈且持久的滤泡辅助性 T 细胞反应。
Cell. 2022 Feb 17;185(4):603-613.e15. doi: 10.1016/j.cell.2021.12.026. Epub 2021 Dec 23.
3
Detection of persistent SARS-CoV-2 IgG antibodies in oral mucosal fluid and upper respiratory tract specimens following COVID-19 mRNA vaccination.
NPJ Vaccines. 2025 Jul 12;10(1):152. doi: 10.1038/s41541-025-01205-x.
4
Prediction and characterisation of the human B cell response to a heterologous two-dose Ebola vaccine.人类对异源两剂埃博拉疫苗的B细胞反应的预测与特征分析
Nat Commun. 2025 Jul 9;16(1):6331. doi: 10.1038/s41467-025-61571-x.
5
Dominant and cross-reactive S1-specific memory B cell response induced by primary SARS-CoV-2 infection.初次感染新型冠状病毒(SARS-CoV-2)诱导产生的显性和交叉反应性S1特异性记忆B细胞应答。
Sci Rep. 2025 Jul 1;15(1):20591. doi: 10.1038/s41598-025-06847-4.
6
Multiscale dynamic immunomodulation by a nanoemulsified Trojan-TLR7/8 adjuvant for robust protection against heterologous pandemic and endemic viruses.纳米乳化特洛伊木马-TLR7/8佐剂的多尺度动态免疫调节作用,用于对异源大流行和地方性病毒的强大保护。
Cell Mol Immunol. 2025 Jun 25. doi: 10.1038/s41423-025-01306-6.
7
Design, optimization, and evaluation of lyophilized lipid nanoparticles for mRNA-based pulmonary mucosal vaccination.基于mRNA的肺部黏膜疫苗冻干脂质纳米颗粒的设计、优化与评价
Mater Today Bio. 2025 May 4;32:101813. doi: 10.1016/j.mtbio.2025.101813. eCollection 2025 Jun.
8
Estimating the prevalence of persistent symptoms after SARS-CoV-2 infection (post-COVID-19 syndrome): a regional cross-sectional study protocol.估计新型冠状病毒2感染后持续症状(新冠后综合征)的患病率:一项区域性横断面研究方案。
BMJ Open. 2025 May 30;15(5):e093844. doi: 10.1136/bmjopen-2024-093844.
9
Pneumococcal vaccine hyporesponsiveness in people living with HIV: A narrative review of immunological mechanisms and insights from minimally invasive lymph node sampling.HIV感染者中肺炎球菌疫苗低反应性:免疫机制的叙述性综述及微创淋巴结采样的见解
Hum Vaccin Immunother. 2025 Dec;21(1):2503602. doi: 10.1080/21645515.2025.2503602. Epub 2025 May 15.
10
Phenotypic heterogeneity defines B cell responses to repeated SARS-CoV-2 exposures through vaccination and infection.表型异质性通过疫苗接种和感染定义了B细胞对反复暴露于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的反应。
Cell Rep. 2025 Apr 22;44(4):115557. doi: 10.1016/j.celrep.2025.115557. Epub 2025 Apr 12.
COVID-19 mRNA 疫苗接种后,在口腔黏膜液和上呼吸道标本中检测到持续的 SARS-CoV-2 IgG 抗体。
Sci Rep. 2021 Dec 27;11(1):24448. doi: 10.1038/s41598-021-03931-3.
4
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2-experienced individuals.在有 SARS-CoV-2 感染史的个体中,单次接种 BNT162b2 mRNA 疫苗后可观察到强大的免疫反应。
Sci Transl Med. 2022 Feb 9;14(631):eabi8961. doi: 10.1126/scitranslmed.abi8961.
5
A large-scale systematic survey of SARS-CoV-2 antibodies reveals recurring molecular features.一项针对新冠病毒抗体的大规模系统性调查揭示了反复出现的分子特征。
bioRxiv. 2021 Nov 30:2021.11.26.470157. doi: 10.1101/2021.11.26.470157.
6
Acute SARS-CoV-2 infection in pregnancy is associated with placental ACE-2 shedding.妊娠期急性SARS-CoV-2感染与胎盘血管紧张素转换酶2(ACE-2)脱落有关。
bioRxiv. 2021 Nov 22:2021.11.19.469335. doi: 10.1101/2021.11.19.469335.
7
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice.变异的 SARS-CoV-2 mRNA 疫苗在小鼠中作为初级或加强系列疫苗具有广泛的中和作用。
Vaccine. 2021 Dec 17;39(51):7394-7400. doi: 10.1016/j.vaccine.2021.11.001. Epub 2021 Nov 8.
8
Human B cell lineages associated with germinal centers following influenza vaccination are measurably evolving.接种流感疫苗后与生发中心相关的人 B 细胞谱系可测地进化。
Elife. 2021 Nov 17;10:e70873. doi: 10.7554/eLife.70873.
9
Equipment-free detection of SARS-CoV-2 and Variants of Concern using Cas13.使用Cas13进行无设备的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及关注变异株检测。
medRxiv. 2021 Nov 2:2021.11.01.21265764. doi: 10.1101/2021.11.01.21265764.
10
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.mRNA 疫苗可诱导对 SARS-CoV-2 及其关注变种的持久免疫记忆。
Science. 2021 Dec 3;374(6572):abm0829. doi: 10.1126/science.abm0829.